Spots Global Cancer Trial Database for arm a
Every month we try and update this database with for arm a cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma | NCT01143311 | Cancer of the S... | Arm A | 40 Years - | Centre Hospitalier Universitaire de Nice | |
| A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer | NCT02079220 | Metastatic Colo... | Arm A Arm B | 18 Years - | University of Pittsburgh | |
| Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor | NCT01176799 | Breast Cancer | Arm A Arm B | 18 Years - | National University Hospital, Singapore | |
| A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer | NCT02079220 | Metastatic Colo... | Arm A Arm B | 18 Years - | University of Pittsburgh | |
| Phase I Study of BI 831266 in Patients With Advanced Solid Tumours | NCT00756223 | Neoplasms | Arm A Arm B | 18 Years - | Boehringer Ingelheim | |
| Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma | NCT01143311 | Cancer of the S... | Arm A | 40 Years - | Centre Hospitalier Universitaire de Nice | |
| Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC | NCT03786692 | Non-Small Cell ... | Arm A Arm B | 18 Years - | Fox Chase Cancer Center | |
| Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC | NCT06061146 | Esophageal Canc... | Arm A Arm A Arm A Arm B Arm B | 70 Years - 90 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases | NCT02358720 | Pain | Arm A Arm B | 18 Years - 80 Years | Heidelberg University | |
| Phase I Study of BI 831266 in Patients With Advanced Solid Tumours | NCT00756223 | Neoplasms | Arm A Arm B | 18 Years - | Boehringer Ingelheim | |
| Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor | NCT01176799 | Breast Cancer | Arm A Arm B | 18 Years - | National University Hospital, Singapore | |
| Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC | NCT06061146 | Esophageal Canc... | Arm A Arm A Arm A Arm B Arm B | 70 Years - 90 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer | NCT01069081 | Breast Cancer Metastasis, Neo... | Arm C Arm B Arm A | 18 Years - | Fudan University | |
| Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer | NCT01069081 | Breast Cancer Metastasis, Neo... | Arm C Arm B Arm A | 18 Years - | Fudan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
